Alex Pharma posts 27.4% profit drop in H1 FY 2021/2022
Updated 2/6/2022 9:36:53 AM
ArabFinance: Alexandria Company for Pharmaceuticals and Chemical Industries (Alex Pharma) (AXPH) reported a 27.45% year-on-year (YoY) decline in net profit after tax for the first half (H1) of fiscal year (FY) 2021/2022, according to the company’s unaudited financial indicators filed to the Egyptian Exchange (EGX).
Net profit after tax amounted to EGP 57.32 million in H1 FY 2021/2022, compared to a profit of EGP 79.005 million in H1 FY 2020/2021.
Revenue slipped by 0.51% YoY to EGP 577.26 million in the July-December period of 2021 from EGP 580.22 million in the same period of 2020.
It is worth noting that the company achieved a net profit after tax of EGP 45.38 million in the first five months of fiscal year (FY) 2021/2022, down by 30% YoY from EGP 64.80 million.
Alex Pharma, a subsidiary of Drug Holding Company, is an Egypt-based company engaged in the manufacture, development, and marketing of pharmaceutical, chemical, veterinary, and nutritional food products, as well as medical appliances.
